Issue 2 2023
-
Annual Meeting officially launches Sunday morning on a mission to advance the frontiers of cancer science
Sunday morning’s Opening Plenary Session borrows its name from the Annual Meeting theme, “Advancing the Frontiers of Cancer Science and Medicine,” and will set the stage for this year’s scientific program, according to Program Committee Chair Robert H. Vonderheide, MD, DPhil.
-
President Biden’s Cancer Moonshot is one of many hot topics at the meeting
NCI Director Monica M. Bertagnolli, MD, will discuss the Cancer Moonshot during a special session on Monday, April 17. It’s one of a handful of sessions at the Annual Meeting that will examine the initiative, which was reignited by President Joe Biden in 2022.
-
AACR President to stress the importance of multidisciplinary approaches to defeat cancer
AACR President Lisa M. Coussens, PhD, FAACR, will encourage collaboration across teams and disciplines during her presidential address Sunday evening. As cancer science delves deeper into chemistry, physics, data science, basic biology, immunology, and other disciplines, collaboration is critical, she said.
-
Schedule highlights from the Program Chair: Sunday, April 16
Annual Meeting Program Committee Chair Robert H. Vonderheide, MD, DPhil, shares a few highlights from Sunday’s schedule to help you plan your day.
-
AACR Lifetime Achievement award recipient lauds ‘great opportunity’ in cell and gene therapies
Carl H. June, MD, FAACR, recipient of the AACR Award for Lifetime Achievement in Cancer Research, will discuss how CAR T-cell therapy is advancing the treatment of cancers and rare diseases during his Sunday award lecture.
-
Nobel Laureate will discuss her work investigating the glycobiology of cancer
Carolyn R. Bertozzi, PhD, recipient of the AACR Award for Outstanding Achievement in Chemistry in Cancer Research, will review her research on glycocalyx for cancer immune therapy during her award lecture Sunday afternoon.
-
Workshop explores opportunities and challenges of AACR Project GENIE genomic data analysis
Alexander S. Baras, MD, PhD, Amin H. Nassar, MD, and Tali Mazor, PhD, demonstrated specific applications of Project GENIE genomic datasets and described how the increasing availability of large clinico-genomic datasets generated through routine cancer care affords the opportunity to conduct precision oncology research using observational data at scale.
-
Senescence appears to drive tumor progression, recurrence
Three researchers — Makoto Nakanishi, MD, PhD, Masashi Narita, MD, PhD, and Clemens A. Schmitt, MD, PhD — discussed the relationship between cellular senescence and cancer during a Saturday morning educational session. “Cellular senescence is at the heart of tissue integrity and tissue homeostasis,” Schmitt said.